Long-term prognostic value of right ventricular dysfunction on cardiovascular magnetic resonance imaging in anthracycline-treated cancer survivors.
Sanya ChhikaraMatthew HooksPal Satyajit Singh AthwalAndrew HughesMohamed F IsmailStephanie JoppaPratik S VelangiPrabhjot S NijjarAnne H BlaesChetan ShenoyPublished in: European heart journal. Cardiovascular Imaging (2021)
Among anthracycline-treated cancer survivors undergoing CMR for suspected cardiotoxicity, RV systolic dysfunction was present in one in five cases, accompanied by LV systolic dysfunction in nearly all cases, and was not independently associated with long-term outcomes.